Evaluation of the CooperVision, Inc. Fanfilcon A and Enfilcon A Daily Wear Contact Lenses When Used for Frequent Replacement for up to One (1) Month of Daily Wear

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

92 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-09-21

Study Completion Date

2016-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is a masked, multi-center, daily wear, monthly replacement, bilateral, randomized, lens blocked (subjects remain in the same lens brand throughout the study) concurrent control study enrolling up to 90 subjects with a study duration of approximately three months. Subjects will be randomized into the study contact lenses in a two to one (2:1) ratio of fanfilcon A lens (test) to enfilcon A lens (control).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

One Month Dispensing Study Comparing the Clinical Performance of the Comfilcon A Sphere Lenses Compared to Comfilcon A Asphere Lenses.

NCT02759471

Myopia

COMPLETED NA

Performance Evaluation of Daily Disposable Contact Lenses in Habitual Lens Wearers Who Use Digital Devices Frequently

NCT05805150

Myopia

COMPLETED NA

Performance of Fanfilcon A Toric Lenses After at Least One Month Wearing Enfilcon A Toric Lenses

NCT02921412

Astigmatism

COMPLETED NA

Evaluation of Delefilcon A and Senofilcon A Daily Disposable Toric Soft Contact Lenses Over Two Weeks of Wear

NCT06161012

Ocular Physiology

COMPLETED NA

Bilateral Dispensing Study of Fanfilcon A Toric Versus Enfilcon A Toric Lenses

NCT02423109

Myopia Hyperopia Astigmatism

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Subjects will be randomized into the study contact lenses in a two to one (2:1) ratio of fanfilcon A lens (test) to enfilcon A lens (control). This should result in a study population of approximately 60 test subjects and 30 control subjects.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myopia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

fanfilcon A (test)

Subjects will be randomized to wear fanfilcon A lens (test) for one month of daily wear during the study.

Group Type EXPERIMENTAL

fanfilcon A (test)

Intervention Type DEVICE

silicone hydrogel lens

enfilcon A (control)

Subjects will be randomized to wear enfilcon A lens (control) for one month of daily wear during the study.

Group Type ACTIVE_COMPARATOR

enfilcon A (control)

Intervention Type DEVICE

silicone hydrogel lens

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

fanfilcon A (test)

silicone hydrogel lens

Intervention Type DEVICE

enfilcon A (control)

silicone hydrogel lens

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Be at least 18 years of age as of the date of evaluation for the study.
* Have:

* Read the Informed Consent
* Been given an explanation of the Informed Consent
* Indicated understanding of the Informed Consent
* Signed the Informed Consent document.
* Be willing and able to adhere to the instructions set forth in this protocol and able to keep all specified appointments.
* Be an adapted, current full-time silicone hydrogel or soft contact lens wearer. An adapted full-time wearer is defined as wearing contact lenses at least 5 days per week for at least 8 hours per day for at least one month prior to participation in the study.
* Possess or obtain prior to dispensing, wearable and visually functional (20/40 or better) eyeglasses.
* Be in good general health, based on his/her knowledge.
* Require spectacle lens powers between -0.50 and -8.00 diopters sphere with no more than 1.50 diopter of refractive astigmatism and be willing to wear contact lenses in both eyes.
* Have manifest refraction Snellen visual acuities (VA) equal to or better than20/25 in each eye.
* To be eligible for lens dispensing, the subject must achieve 20/30 VA or better in each eye with the study lens and the investigator must judge the fit as acceptable or optimal.

Exclusion Criteria

* Wearing lenses in a monovision modality and is unwilling to be fit with distance lenses in both eyes for the duration of the study. Note: Subjects may not wear lenses in a monovision modality at any time during the study as it will interfere with the visual acuity analysis.
* Poor personal hygiene.
* Any active participation in another clinical trial during this trial or within 30 days prior to this study.
* To the best of the subject's knowledge, she is currently pregnant, is lactating or is planning a pregnancy within the next 3 months.
* A member, relative or household member of the investigator or of the investigational office staff.
* Has a known sensitivity to the ingredients used in the Multi-Purpose Disinfection Lens Care System (MPS) approved for use in the study and is unable or unwilling to use the alternate care system.
* Previous refractive surgery; or current or previous orthokeratology treatment.
* Is aphakic or pseudophakic.
* Ocular or systemic disease such as, but not limited to: anterior uveitis or iritis (past or present), glaucoma, Sjögren's syndrome, lupus erythematosus, scleroderma, keratoconus or uncontrolled diabetes.
* The need for topical ocular medications or any systemic medication which might interfere with contact lens wear or require the lenses to be removed during the day.
* The presence of clinically significant (grade 2, 3 or 4) anterior segment abnormalities; or the presence of any inflammations such as iritis; or any infection of the eye, lids, or associated structures.
* A known history of corneal hypoesthesia (reduced corneal sensitivity), corneal ulcer, corneal infiltrates, iritis, bacterial or fungal infections.
* A history of papillary conjunctivitis that has interfered with contact lens wear.
* Slit lamp findings that would contraindicate contact lens wear, including but not limited to:

* Pathological dry eye or associated dry eye symptoms with decreased tear levels and punctuate staining \> Grade 2
* Pterygium
* Corneal scars within the visual axis
* Neovascularization or ghost vessels \> 1.0 mm in from the limbus
* Giant papillary conjunctivitis (GPC) of \> Grade 2
* Anterior uveitis or iritis
* Seborrheic eczema, seborrheic conjunctivitis or blepharitis

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No